Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine

The Influence of Innate and Adaptive Immune Responses on Atherosclerosis

(2013) Joseph L. Witztum et al.   Annual Review of Pathology-Mechanisms of Disease

Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans

(2013) Peter Libby et al.   IMMUNITY

Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques

(2013) Chunguang Wang et al.   INTERNATIONAL IMMUNOLOGY

Adaptive immunity in atherogenesis: new insights and therapeutic approaches

(2013) Andrew H. Lichtman et al.   JOURNAL OF CLINICAL INVESTIGATION

Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors

(2013) Erica N. Montano et al.   JOURNAL OF LIPID RESEARCH

Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities

(2013) I. Tabas et al.   SCIENCE

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100

(2013) Kevin Tse et al.   Frontiers in Immunology

Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice

(2012) Olivier Herbin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein B100 autoimmunity and atherosclerosis – disease mechanisms and therapeutic potential

(2012) Jan Nilsson et al.   CURRENT OPINION IN LIPIDOLOGY

Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions

(2012) Rogier A. van Dijk et al.   JOURNAL OF LIPID RESEARCH

Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease

(2012) Shahzada Amir et al.   JOURNAL OF LIPID RESEARCH

Immunotherapy With Tolerogenic Apolipoprotein B-100–Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic Mice

(2011) Andreas Hermansson et al.   CIRCULATION

Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity

(2011) Yury I. Miller et al.   CIRCULATION RESEARCH

Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression

(2011) Sotirios Tsimikas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Progress and challenges in translating the biology of atherosclerosis

(2011) Peter Libby et al.   NATURE

Complement factor H binds malondialdehyde epitopes and protects from oxidative stress

(2011) David Weismann et al.   NATURE

Autoimmune Hepatitis Induced by Syngeneic Liver Cytosolic Proteins Biotransformed by Alcohol Metabolites

(2010) Geoffrey M. Thiele et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Malondialdehyde–acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis

(2010) Michael J. Duryee et al.   FREE RADICAL BIOLOGY AND MEDICINE

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans

(2009) Meng-Yun Chou et al.   JOURNAL OF CLINICAL INVESTIGATION

Vaccination against atherosclerosis? Induction of atheroprotective immunity

(2009) Göran K. Hansson et al.   Seminars in Immunopathology